Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer(NSCLC) (OITROLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02076477
Recruitment Status : Recruiting
First Posted : March 3, 2014
Last Update Posted : March 17, 2020
Sponsor:
Collaborators:
Mianyang Central Hospital
Cancer Hospital of Guizhou Province
Information provided by (Responsible Party):
LI TAO, Sichuan Cancer Hospital and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2020